Oncocyte Corp Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Oncocyte Corp quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Oncocyte Corp Operating Lease, Payments for the quarter ending March 31, 2024 was $272K, a 4.9% decline year-over-year.
  • Oncocyte Corp annual Operating Lease, Payments for 2023 was $1.05M, a 8.31% decline from 2022.
  • Oncocyte Corp annual Operating Lease, Payments for 2022 was $1.14M, a 9.69% increase from 2021.
  • Oncocyte Corp annual Operating Lease, Payments for 2021 was $1.04M, a 88.8% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.05M -$95K -8.31% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $1.14M +$101K +9.69% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $1.04M +$490K +88.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-12
2020 $552K +$517K +1477% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $35K Jan 1, 2019 Dec 31, 2019 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.